Emcure Pharmaceuticals Share Price

ABOUT Emcure Pharmaceuticals

• ISIN INE168P01015
• BSE Code 544210
• NSE Code EMCURE

Emcure Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas. It offers a range of products and services under formulations, biologics, and Active Pharmaceutical Ingredients (APIs). It focuses on various key therapeutic areas, such as gynecology, cardiology, anti-infective, diabetes, biologics, mRNA vaccines, and vitamin, minerals and nutrients. It offers products in both, chronic and acute segments. The Company's subsidiary, Gennova Biopharmaceuticals Limited, is a biotechnology company dedicated to developing, producing, and commercializing bio-therapeutics to address life-threatening diseases across various indications. It has developed two platforms: Mammalian and Microbial. Its key APIs consists of S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate, and Eribulin. It operates approximately 13 manufacturing facilities.

MANAGEMENT

• Satish Mehta Chief Executive Officer, Managing Director, Executive Director
• Tajuddin Shaikh Chief Financial Officer
• Chetan Sharma Company Secretary, Compliance Officer
• Mukund Gurjar Whole Time Director
• Samit Mehta Whole Time Director
• Sunil Mehta Whole Time Director
• Namita Thapar Whole Time Director